RILPL2 and non-small cell lung carcinoma: Following this, our investigative focus pivoted towards an intricate examination of the interplay between RILPL2 expression and a myriad of clinicopathological features within a cohort comprising 140 patients afflicted with primary NSCLC, the final analysis showed that there was a significant correlation between RILPL2 expression and clinical stage (P = 0.019) (Table 1), with low RILPL2 expression indicative of a more advanced stage.